In recent years, some women who used talcum powder as part of their daily routine have developed ovarian cancer. Presently, more than 1000 women and surviving family members have filed suit against Johnson & Johnson, the makers of Johnson's Baby Powder and Shower to Shower. In 2016, juries in Missouri ordered Johnson & Johnson to pay $72 million and $55 million respectively in cases involving long-time talc users who developed ovarian cancer.
For decades members of the medical and scientific communities have published studies linking talcum powder use and an increased risk of ovarian cancer. While the exact reason for this link is the subject of ongoing research, many believe talc particles enter the vagina and migrate to the ovaries. While some scientists do not believe this connection has been proven conclusively, others believe there is a strong link between talc usage and a heightened ovarian cancer risk.
For more than a century, Johnson & Johnson has manufactured and sold talcum powder. This product is sold as Johnson's Baby Powder and is used both by parents of young children and adults. Baby powder is composed primarily of talc. For decades, many studies in the medical community have linked the long-term use of talcum powder and a higher risk of ovarian cancer.